Latest Options News

EMVision Medical Devices has closed its $2 million Share Purchase Plan ahead of schedule due to strong investor demand, signaling robust market interest in its neurodiagnostic technology.

Nyrada has completed its Phase I trial for Xolatryp, confirming safety and predictable pharmacokinetics, while securing AU$8.25 million to fund an upcoming Phase IIa trial targeting heart attack patients.

Solis Minerals has entered a binding agreement to acquire up to 75% of the Cucho Copper Project in Peru, a large-scale porphyry system with promising historical drilling results and significant untested exploration targets. The company plans a 5,000-metre drilling program in 2026 aiming for a maiden resource estimate and economic assessment.

Theta Gold Mines has secured an additional US$6 million from cornerstone investors and converted outstanding convertible loans into shares and options, reinforcing its balance sheet as it advances the TGME Gold Project in South Africa.

Bass Oil Limited reported a 3% rise in September oil production, driven by a 20% uplift in Indonesian output, while awaiting regulatory approval for a strategic gas field acquisition.

Invion Limited has partnered with Protect Animal Health to explore Photosoft™, a novel photodynamic therapy, as a treatment for cancer in companion animals, targeting a booming pet cancer market.

Tasman Resources has raised $2 million through a two-tranche placement to fund a promising drilling campaign at Parkinson Dam and broaden its project portfolio, alongside appointing a new director to steer its strategic ambitions.

Moho Resources has raised $2 million through a share placement to fund an extensive drilling and sampling campaign at its Bush Chook Project, aiming to validate historical gold anomalies and expand its resource base.

Lithium Universe Limited has raised $2.5 million through a placement to advance its lithium refinery in Québec and innovative solar panel recycling technology. The funding highlights investor confidence in the company’s dual strategy to close North America’s lithium supply gap and pioneer sustainable metal recovery.

Helloworld Travel Limited has completed its acquisition of the remaining 50% stake in Mobile Travel Holdings, fully owning the mobile travel agency and significantly boosting its transaction volume.

South Harz Potash Limited is progressing its transition to a dual-asset strategy, raising A$2.58 million to support expansion while adopting a cautious approach to its core German potash project amid market weakness.

PYC Therapeutics has kicked off a global Phase 1b repeat dose study of its investigational drug PYC-001 targeting Autosomal Dominant Optic Atrophy, a rare genetic eye disease with no current treatments. Initial dosing has begun, with key data expected in the second half of 2026.